• Clasto-Lactacystin β-lactone: Strategic Leverage in Proteaso

  2026-04-25

  This article delivers advanced, evidence-based guidance for translational researchers seeking to harness the mechanistic power and workflow reliability of Clasto-Lactacystin β-lactone, integrating recent viral immunology findings on the ubiquitin-proteasome system with practical assay strategies and outlooks for disease modeling.

• Sodium Picosulfate: Precision Tool for Gut–Liver–Brain Axis

  2026-04-24

  Explore how Sodium Picosulfate enables advanced, reproducible modeling of gut–liver–brain interactions and neuroinflammation. This deep-dive reveals unique experimental strategies and critical protocol details for translational research.

• Pickering Emulsions Enhance mRNA Vaccine Delivery for Cancer

  2026-04-24

  This thesis introduces a multi-level Pickering emulsion system for cancer vaccine delivery, demonstrating enhanced antigen loading, dendritic cell activation, and tumor suppression compared to traditional adjuvants. The work provides a foundation for safer, more effective mRNA-based immunotherapy platforms.

• Optimizing Platelet Differentiation from hiPSCs: Protocol Ad

  2026-04-23

  This study presents an optimized, cost-effective method for generating functional platelets from human induced pluripotent stem cells (hiPSCs), utilizing higher embryoid body cell input, small molecule-driven maturation, and human platelet lysate supplementation. The protocol shortens differentiation time, enhances platelet yield, and reduces costs, offering translational potential for regenerative and transfusion medicine.

• Scalable EPSC-iMSC Extracellular Vesicle Production for Ther

  2026-04-23

  Gong et al. introduce a robust, bioreactor-based platform for generating extracellular vesicles (EVs) from induced mesenchymal stem cells (iMSCs) derived from extended pluripotent stem cells (EPSCs). This standardized system overcomes key challenges in EV production, enabling consistent, high-yield therapeutic vesicles suitable for translational research and potential clinical application.

• (S)-Mephenytoin: Advanced CYP2C19 Substrate for In Vitro Met

  2026-04-22

  (S)-Mephenytoin is the benchmark CYP2C19 substrate for in vitro pharmacokinetic assays, especially within organoid-based and hiPSC-derived intestinal models. Its precise kinetic parameters and robust reproducibility empower researchers to bridge bench assays and clinical insights with unmatched fidelity.

• Apoptotic Sensitivity in Glioblastoma Enables BH3-Mimetic Th

  2026-04-22

  This article analyzes a study demonstrating that glioblastoma (GBM) cells exhibit increased levels of anti-apoptotic BCL-xL and MCL-1, making them highly susceptible to targeted apoptosis induction by BH3-mimetic compounds. The findings highlight a potential therapeutic vulnerability in GBM and outline the experimental rationale for selective BCL-XL inhibition.

• GSK126 EZH2 Inhibitor: Expanding Horizons in Cancer and HIV

  2026-04-21

  This article delivers an advanced, mechanistically anchored perspective on GSK126 as a selective EZH2 inhibitor, blending robust evidence from cancer epigenetics and novel findings in neurovirology. It guides translational researchers through the biological rationale, experimental validation, and emerging cross-domain relevance of GSK126, contextualized by both competitive landscape analysis and workflow optimization. Drawing on peer-reviewed research, including the pivotal role of H3K27me3 in HIV latency, and referencing prior thought-leadership content, this piece provides actionable insights for deploying GSK126 in both oncology and latent viral reservoir research.

• Antiviral lncRNA EDAL Promotes EZH2 Degradation via O-GlcNAc

  2026-04-21

  Sui et al. identify a neuronal lncRNA, EDAL, that restricts neurotropic virus replication by targeting the epigenetic regulator EZH2 for lysosomal degradation through interference with O-GlcNAcylation at T309. This mechanism reveals a novel, interferon-independent antiviral pathway and suggests new directions for research into epigenetic regulation in CNS antiviral defense.

• Stiripentol as a Precision LDH Inhibitor: Beyond Epilepsy Re

  2026-04-20

  Explore Stiripentol, a cutting-edge LDH inhibitor, as a research tool for dissecting lactate metabolism and epigenetic regulation. This article offers a deeper, evidence-based analysis of its mechanistic role and expands on its unique value in the context of metabolic-immune crosstalk.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody: Workflow Advances

  2026-04-20

  The FITC Goat Anti-Rabbit IgG (H+L) Antibody from APExBIO excels in high-sensitivity immunofluorescence, enabling robust detection of low-abundance biomarkers. This article explores advanced workflows, troubleshooting tips, and practical insights to maximize signal amplification and specificity in translational research.

• Bovine Liver Organoids Advance Fatty Liver Disease Modeling

  2026-04-19

  Lei et al. developed a bovine liver organoid model to replicate and investigate fatty liver disease in dairy cows. This innovation offers a physiologically relevant platform for studying disease mechanisms and screening interventions, reducing reliance on live animal experiments.

• Pleiotrophin’s Role in BPH: Modulation of Proliferation and

  2026-04-18

  Liu et al. provide compelling evidence that pleiotrophin (PTN) modulates cell proliferation, smooth muscle contraction, and fibrosis in the pathogenesis of benign prostatic hyperplasia (BPH). Their integrative use of human tissues, cell models, and animal systems identifies PTN as a regulator of key signaling axes, suggesting new therapeutic avenues and research strategies for BPH.

• Applied MCC950 Sodium Workflows for NLRP3 Inflammasome Resea

  2026-04-17

  MCC950 sodium (CRID3 sodium salt) enables precise, reproducible dissection of NLRP3-driven inflammation in both endothelial and macrophage models. This guide translates recent mechanistic findings into actionable protocols while providing troubleshooting insights for robust inflammatory disease research.

• Optimizing Redox Assays with GKT137831: Scenario-Driven Solu

  2026-04-16

  This article delivers scenario-driven, evidence-based guidance for optimizing cell viability and oxidative stress assays with GKT137831 (SKU B4763), a dual NADPH oxidase Nox1/Nox4 inhibitor. Researchers will find practical, literature-backed answers to common workflow challenges, making GKT137831 a reliable choice for reproducible and insightful redox biology research.

11744 records 1/783 page Next 12345 下5页 Last page